Showing results (611-620 of 1,398) with videos related to

Sort By:
Pageof 140
Drug Development Research|May 27, 2024
Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen speciesChaowen Wang, Wenjing Zeng, Li Wang, et al.
Drug Development Research|May 29, 2024
Repurposing of drugs against bacterial infections: A pharmacovigilance-based data mining approachSimran Ohra, Ruchika Sharma, Anoop Kumar
Drug Development Research|June 4, 2024
Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulationAhmed Ragab, Mohamed A Salem, Yousry A Ammar, et al.
Drug Development Research|April 29, 2024
A review of natural products and small-molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challengesArdalan Pasdaran, Irwin Darren Grice, Azadeh Hamedi
Drug Development Research|April 28, 2024
Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validationXiujun Yang, Qun Liu, Gang Li
Drug Development Research|November 14, 2023
Investigation of the activity of a novel tropolone in osteosarcomaStaci L Haney, Dan Feng, Sai Sundeep Kollala, et al.
Drug Development Research|November 16, 2023
Design, synthesis of novel chromene-based scaffolds targeting hepatocellular carcinoma: Cell cycle arrest, cytotoxic effect against resistant cancer cells, apoptosis induction, and c-Src inhibitionEman K A Abdelall, Heba A H Elshemy, Madlen B Labib, et al.
Drug Development Research|November 9, 2023
Function of proprotein convertase subtilisin/kexin type 9 and its role in central nervous system diseases: An update on clinical evidenceXiao-Bin Zhu, Yao-Yao Xu, Liu-Cheng Li, et al.
Drug Development Research|October 4, 2024
89Zr-Labeled DFO@Durvalumab-HSA nanoparticles: In vitro potential for triple-negative breast cancerFatma Yurt, Derya Özel, Şeyma Karagül, et al.
Drug Development Research|October 9, 2024
Tropisetron attenuates high glucose-induced oxidative stress and inflammation in ARPE-19 cells in vitro via regulating SIRT1/ROCK1 signalingMingxia Tang, Wei Liu
Pageof 140